Log In
Print this Print this

Fovista (formerly E10030)

  Manage Alerts
Collapse Summary General Information
Company Ophthotech Corp.
DescriptionPegylated aptamer against platelet derived growth factor B (PDGFB; PDGF2)
Molecular Target Platelet derived growth factor B (PDGFB) (PDGF2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Aptamer
Latest Stage of DevelopmentPhase III
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD); Treat wet age-related macular degeneration (AMD)
Regulatory Designation
Partner Novartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today